Drugs Approvals Hit A New High In 2017

 Drugs approvals hit a new high in 2017

With 46 novel medicines winning approval nods, U.S. drug approvals saw a 21-year high in 2017. It statistics to be believed, it is more than twice the last year’s. The European Union also saw a significant rise.

While European Union laid out recommendation for 92 drugs including generics, China came out with new strategies and plans to speed up approvals and has now become the world’s second biggest market behind the U.S.


    Deloitte said 22 of the world’s top-listed drug makers projected returns of 3.2 percent, which was an eight-year low.

Most of the drugs that won approval in 2017 were for sub-types of cancer and rare diseases, which sometimes target comparatively smaller populations, however, they can cost thousands of dollars.


Our App

Connect with us

Oddway on facebook Oddway on pinterest Oddway on VK Oddway on LinkedIn Oddway on Twitter

Contact Us

  • icon
    Address : 4216/20, Ground Floor, 1 Ansari Road, Daryaganj,
               New Delhi - 110002 (India)
  • icon
    Phone : +91-11-43526658
    Mobile : +91-9873336444
  • icon
    WhatsApp : +91-9873336444
    Viber          : +91-9873336444

Oddway International is a Pharmaceutical Exporter & Supplier of Generic Medicine and Online Pharmacy Distributor in India...Read More